BioNTech SE ADR buy BlueGraySphere
Start price
26.02.21
/
30%
€92.40
Target price
26.02.22
€150.00
Performance (%)
40.64%
End price
27.02.22
€129.95
Summary
This prediction ended on 27.02.22 with a price of €129.95. With a performance of 40.64% the BUY prediction by BlueGraySphere was a big success. BlueGraySphere has 30% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
According to BlueGraySphere what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Market Leader or Top 3
Very small cyclical dependencies
Very Future proof/growth oriented business model
Leading role in innovation
Could be very worthwhile Investment >20% year
Well known brand
Cons
High risks for its business
Dependend from few customers or products
Comments by BlueGraySphere for this prediction
In the thread Biontech SE diskutieren
Buy mit Kursziel 150,0
In the thread Trading Biontech SE
Die von BlueGraySphere gewählte maximale Laufzeit wurde überschritten